83 FR 1377 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 8 (January 11, 2018)

Page Range		1377-1378
FR Document		2018-00297
Federal Register, Volume 83 Issue 8 (Thursday, January 11, 2018)
[Federal Register Volume 83, Number 8 (Thursday, January 11, 2018)]
[Notices]
[Pages 1377-1378]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00297]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant and/or contract proposals applications 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel TEP-9B: Cancer Cachexia Therapy.
    Date: February 6, 2018.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].
    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Informatics Technologies for Cancer Research 
and Management.
    Date: February 8-9, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Cambria Hotel & Suites Rockville, 1 Helen Henghan Way, 
Rockville, MD 20892.
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Bethesda, MD 20892-9750, 240-276-5179, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project V (P01) Review.
    Date: February 14-15, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review 
Officer, Office of the Director, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W514, Bethesda, MD 20892-9750, 240-276-6340, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular Analysis Technologies (IMAT).
    Date: February 15, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W424, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Pancreatic Cancer Detection Consortium (U01).
    Date: February 15, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W240, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5A: NCI Clinical and Translational Exploratory/
Developmental Studies.
    Date: February 15, 2018.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UH2 Review.
    Date: February 27, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R25 Review.
    Date: February 28, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R01 Multi-Site.
    Date: March 6, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].


[[Page 1378]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Outstanding Investigator Award (OIA) II.
    Date: March 8-9, 2018.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Caron A. Lyman, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-9--Drug Development.
    Date: March 9, 2018.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-1: Development of Software Tools for Post Radiation 
Therapy Surveillance.
    Date: March 13-14, 2018.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Emerging Questions in Cancer Systems Biology (U01).
    Date: March 16, 2018.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2E908, Rockville, MD 20850.
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: January 5, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00297 Filed 1-10-18; 8:45 am]
BILLING CODE 4140-01-P
Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices 1377

Contact Person: Chee Lim, Ph.D., Scientific Contact Person: Jun Fang, Ph.D., Scientific 20892–9750, 240–276–5122, hasan.siddiqui@
Review Officer, Center for Scientific Review, Review Officer, Research Technology and nih.gov.
National Institutes of Health, 6701 Rockledge Contract Review Branch, Division of Name of Committee: National Cancer
Drive, Room 4128, Bethesda, MD 20892, 301– Extramural Activities, National Cancer Institute Special Emphasis Panel; SEP–5A:
435–1850, limc4@csr.nih.gov. Institute, NIH, 9609 Medical Center Drive, NCI Clinical and Translational Exploratory/
Name of Committee: Center for Scientific Room 7W246, Bethesda, MD 20892–9750, Developmental Studies.
Review Special Emphasis Panel; Academic 240–276–5460, jfang@mail.nih.gov. Date: February 15, 2018.
Research Enhancement Award. Name of Committee: National Cancer Time: 11:00 a.m. to 4:00 p.m.
Date: February 16, 2018. Institute Special Emphasis Panel; Agenda: To review and evaluate grant
Time: 1:00 p.m. to 5:00 p.m. Development of Informatics Technologies for applications.
Agenda: To review and evaluate grant Cancer Research and Management. Place: National Cancer Institute, Shady
applications. Date: February 8–9, 2018. Grove, 9609 Medical Center Drive, Room
Place: National Institutes of Health, 6701 Time: 5:00 p.m. to 5:00 p.m. 7W238, Rockville, MD 20850 (Telephone
Rockledge Drive, Bethesda, MD 20892. Agenda: To review and evaluate grant Conference Call).
Contact Person: Inna Gorshkova, Ph.D., applications. Contact Person: Byeong-Chel Lee, Ph.D.,
Place: Cambria Hotel & Suites Rockville, 1 Scientific Review Officer, Resources and
Scientific Review Officer, Center for
Helen Henghan Way, Rockville, MD 20892. Training Review Branch, Division of
Scientific Review, National Institutes of
Contact Person: Saejeong J. Kim, Ph.D., Extramural Activities, National Cancer
Health, 6701 Rockledge Drive, Bethesda, MD
Scientific Review Officer, Special Review Institute, NIH, 9609 Medical Center Drive,
20892, 301–435–1784, gorshkoi@csr.nih.gov.
Branch, Division of Extramural Activities, Room 7W238, Bethesda, MD 20892–9750,
(Catalogue of Federal Domestic Assistance National Cancer Institute, NIH, 9609 Medical
Program Nos. 93.306, Comparative Medicine; 240–276–7755, byeong-chel.lee@nih.gov.
Center Drive, Room 7W640, Bethesda, MD
93.333, Clinical Research, 93.306, 93.333, 20892–9750, 240–276–5179, saejeong.kim@ Name of Committee: National Cancer
93.337, 93.393–93.396, 93.837–93.844, nih.gov. Institute Special Emphasis Panel; UH2
93.846–93.878, 93.892, 93.893, National Review.
Name of Committee: National Cancer Date: February 27, 2018.
Institutes of Health, HHS) Institute Special Emphasis Panel; NCI Time: 1:00 p.m. to 4:00 p.m.
Dated: January 8, 2018. Program Project V (P01) Review. Agenda: To review and evaluate grant
Melanie J. Pantoja, Date: February 14–15, 2018. applications.
Time: 5:00 p.m. to 5:00 p.m.
Program Analyst, Office of Federal Advisory Place: National Cancer Institute, Shady
Agenda: To review and evaluate grant
Committee Policy. Grove, 9609 Medical Center Drive, Room
applications.
[FR Doc. 2018–00388 Filed 1–10–18; 8:45 am] 7W608, Rockville, MD 20850 (Telephone
Place: Gaithersburg Marriott
Conference Call).
BILLING CODE 4140–01–P Washingtonian Center, 9751 Washingtonian
Contact Person: Robert E. Bird, Ph.D.,
Boulevard, Gaithersburg, MD 20878.
Scientific Review Officer, Research Program
Contact Person: Wlodek Lopaczynski, MD,
Review Branch, Division of Extramural
DEPARTMENT OF HEALTH AND Ph.D., Scientific Review Officer, Office of the
Activities, National Cancer Institute, NIH,
HUMAN SERVICES Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical 9609 Medical Center Drive, Room 7W608,
Center Drive, Room 7W514, Bethesda, MD Bethesda, MD 20892–9750, 240–276–6344,
National Institutes of Health birdr@mail.nih.gov.
20892–9750, 240–276–6340, lopacw@
mail.nih.gov. Name of Committee: National Cancer
National Cancer Institute; Notice of Institute Special Emphasis Panel; R25
Closed Meetings Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative Review.
Molecular Analysis Technologies (IMAT). Date: February 28, 2018.
Pursuant to section 10(d) of the Time: 1:00 p.m. to 4:00 p.m.
Federal Advisory Committee Act, as Date: February 15, 2018.
Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant
amended, notice is hereby given of the applications.
Agenda: To review and evaluate grant
following meetings. applications. Place: National Cancer Institute, Shady
The meetings will be closed to the Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room
public in accordance with the Grove, 9609 Medical Center Drive, Room 7W608, Rockville, MD 20850 (Telephone
7W030, Rockville, MD 20850 (Telephone Conference Call).
provisions set forth in sections
Conference Call). Contact Person: Robert E. Bird, Ph.D.,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Research Program
as amended. The grant and/or contract Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Research Review Branch, Division of Extramural
proposals applications and the Technology and Contract Review Branch, Activities, National Cancer Institute, NIH,
discussions could disclose confidential Division of Extramural Activities, National 9609 Medical Center Drive, Room 7W608,
trade secrets or commercial property Cancer Institute, NIH, 9609 Medical Center Bethesda, MD 20892–9750, 240–276–6344,
such as patentable material, and Drive, Room 7W424, Bethesda, MD 20892– birdr@mail.nih.gov.
personal information concerning 9750, 240–276–5287, yasuko.furumoto@ Name of Committee: National Cancer
individuals associated with the grant nih.gov. Institute Special Emphasis Panel; R01 Multi-
and/or contract proposals applications, Name of Committee: National Cancer Site.
the disclosure of which would Institute Special Emphasis Panel; Pancreatic Date: March 6, 2018.
Cancer Detection Consortium (U01). Time: 1:00 p.m. to 5:00 p.m.
constitute a clearly unwarranted
Date: February 15, 2018. Agenda: To review and evaluate grant
invasion of personal privacy. applications.
Time: 11:00 a.m. to 1:00 p.m.
Name of Committee: National Cancer Agenda: To review and evaluate grant Place: National Cancer Institute, Shady
Institute Special Emphasis Panel TEP–9B: applications. Grove, 9609 Medical Center Drive, Room
Cancer Cachexia Therapy. Place: National Cancer Institute, Shady 7W608, Rockville, MD 20850 (Telephone
srobinson on DSK9F5VC42PROD with NOTICES

Date: February 6, 2018. Grove, 9609 Medical Center Drive, Room Conference Call).
Time: 10:00 a.m. to 12:00 p.m. 7W240, Rockville, MD 20850 (Telephone Contact Person: Robert E. Bird, Ph.D.,
Agenda: To review and evaluate contract Conference Call). Scientific Review Officer, Research Program
proposals. Contact Person: Hasan Siddiqui, Ph.D., Review Branch, Division of Extramural
Place: National Cancer Institute, Shady Scientific Review Officer, Special Review Activities, National Cancer Institute, NIH,
Grove, 9609 Medical Center Drive, Room Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W608,
7W030, Rockville, MD 20850 (Telephone National Cancer Institute, NIH 9609, Medical Bethesda, MD 20892–9750, 240–276–6344,
Conference Call). Center Drive, Room 7W240, Bethesda, MD birdr@mail.nih.gov.

VerDate Sep<11>2014 00:05 Jan 11, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\11JAN1.SGM 11JAN1
1378 Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices

Name of Committee: National Cancer Treatment Research; 93.396, Cancer Biology Designated Federal Officer (see contact
Institute Special Emphasis Panel; Research; 93.397, Cancer Centers Support; information below).
Outstanding Investigator Award (OIA) II. 93.398, Cancer Research Manpower; 93.399, Substantive program information may
Date: March 8–9, 2018. Cancer Control, National Institutes of Health, be obtained after the meeting by
Time: 8:00 a.m. to 1:00 p.m. HHS)
Agenda: To review and evaluate grant
accessing the SAMHSA Committee
applications. Dated: January 5, 2018. website, http://nac.samhsa.gov/, or by
Place: Gaithersburg Marriott Melanie J. Pantoja, contacting the Designated Federal
Washingtonian Center, 9751 Washingtonian Program Analyst, Office of Federal Advisory Officer.
Boulevard, Gaithersburg, MD 20878. Committee Policy. Committee Name: Substance Abuse and
Contact Person: Caron A. Lyman, Ph.D., Mental Health Services Administration,
[FR Doc. 2018–00297 Filed 1–10–18; 8:45 am]
Scientific Review Officer, Research Program Center for Substance Abuse Prevention
Review Branch, Division of Extramural BILLING CODE 4140–01–P
National Advisory Council.
Activities, National Cancer Institute, NIH, Date/Time/Type: February 14, 2018, from
9609 Medical Center Drive, Room 7W126, 9:30 a.m. to 4:30 p.m. EST: (OPEN).
Bethesda, MD 20892–9750, 240–276–6348, DEPARTMENT OF HEALTH AND
Place: SAMHSA, 5600 Fishers Lane, Room
lymanc@mail.nih.gov. HUMAN SERVICES 5A02, Rockville, MD 20852, Adobe Connect
Name of Committee: National Cancer webcast: https://samhsa-
Institute Special Emphasis Panel; SEP–9— Substance Abuse and Mental Health csap.adobeconnect.com/nac/.
Drug Development. Services Administration Contact: Matthew J. Aumen, Designated
Date: March 9, 2018. Federal Officer, SAMHSA CSAP NAC, 5600
Time: 9:00 a.m. to 6:00 p.m. Center for Substance Abuse Fishers Lane, Rockville, MD 20852,
Agenda: To review and evaluate grant Prevention; Notice of Meeting Telephone: 240–276–2440, Fax: 301–480–
applications. 8480, Email: matthew.aumen@
Place: National Cancer Institute, Shady Pursuant to Public Law 92–463, samhsa.hhs.gov.
Grove, 9609 Medical Center Drive, Room notice is hereby given for the meeting of
7W114, Rockville, MD 20850 (Telephone the Substance Abuse and Mental Health Carlos Castillo,
Conference Call). Services Administration’s (SAMHSA) Committee Management Officer, SAMHSA.
Contact Person: Jeffrey E. DeClue, Ph.D., Center for Substance Abuse Prevention [FR Doc. 2018–00369 Filed 1–10–18; 8:45 am]
Scientific Review Officer, Research
National Advisory Council (CSAP NAC) BILLING CODE 4162–20–P
Technology and Contract Review Branch,
Division of Extramural Activities, National on February 14, 2018.
Cancer Institute, NIH, 9609 Medical Center The Council was established to advise
Drive, Room 7W114, Bethesda, MD 20892– the Secretary, Department of Health and DEPARTMENT OF THE INTERIOR
9750, 240–276–6371, decluej@mail.nih.gov. Human Services (HHS); the Assistant
Name of Committee: National Cancer Secretary for Mental Health and Fish and Wildlife Service
Institute Special Emphasis Panel; TEP–1: Substance Use, SAMHSA; and Director, [Docket No. FWS–HQ–IA–2017–0086;
Development of Software Tools for Post CSAP concerning matters relating to the FXIA16710900000–178–FF09A30000]
Radiation Therapy Surveillance. activities carried out by and through the
Date: March 13–14, 2018. Center and the policies respecting such Foreign Endangered and Threatened
Time: 4:00 p.m. to 5:00 p.m. Species; Receipt of Permit
Agenda: To review and evaluate contract
activities.
proposals. The meeting will be open to the Applications
Place: Bethesda North Marriott Hotel & public and will include the discussion AGENCY: Fish and Wildlife Service,
Conference Center, 5701 Marinelli Road, of the substance use prevention Interior.
North Bethesda, MD 20852. workforce and opioid use prevention.
Contact Person: Shakeel Ahmad, Ph.D., ACTION: Notice of receipt of permit
The meeting will also include updates applications.
Scientific Review Officer, Research on CSAP program developments.
Technology and Contract Review Branch,
Division of Extramural Activities, National The meeting will be held in Rockville, SUMMARY: We, the U.S. Fish and
Cancer Institute, NIH, 9609 Medical Center Maryland. Attendance by the public Wildlife Service, invite the public to
Drive, Room 7W102, Bethesda, MD 20892– will be limited to the space available. comment on applications to conduct
9750, 240–276–6349, ahmads@mail.nih.gov. Interested persons may present data, certain activities with foreign
Name of Committee: National Cancer information, or views, orally or in endangered and threatened species.
Institute Special Emphasis Panel; Emerging writing, on issues pending before the With some exceptions, the Endangered
Questions in Cancer Systems Biology (U01). Council. Written submissions should be Species Act prohibits activities with
Date: March 16, 2018. forwarded to the contact person on or listed species unless Federal
Time: 8:00 a.m. to 4:00 p.m. before one week prior to the meeting. authorization is acquired that allows
Agenda: To review and evaluate grant such activities. The ESA also requires
Oral presentations from the public will
applications.
Place: National Cancer Institute, Shady be scheduled at the conclusion of the that we invite public comment before
Grove, 9609 Medical Center Drive, Room meeting. Individuals interested in issuing these permits.
2E908, Rockville, MD 20850. making oral presentations should notify DATES: We must receive comments by
Contact Person: Timothy C. Meeker, MD, the contact on or before one week prior February 12, 2018.
Scientific Review Officer, Resources and to the meeting. Five minutes maximum ADDRESSES:
Training Review Branch, Division of will be allotted for each presentation. Document availability: The
Extramural Activities, National Cancer
To attend onsite, submit written or applications, as well as any comments
srobinson on DSK9F5VC42PROD with NOTICES

Institute, NIH, 9609 Medical Center Drive,
Room 7W606, Bethesda, MD 20892–9750, brief oral comments, or request special and other materials that we receive, will
240–276–6464, meekert@mail.nih.gov. accommodations for persons with be available for public inspection online
(Catalogue of Federal Domestic Assistance disabilities, please register at the in Docket No. FWS–HQ–IA–2017–0086
Program Nos. 93.392, Cancer Construction; SAMHSA Committees’ website, http:// at http://www.regulations.gov.
93.393, Cancer Cause and Prevention nac.samhsa.gov/Registration/ Submitting comments: You may
Research; 93.394, Cancer Detection and meetingsRegistration.aspx, or submit comments by one of the
Diagnosis Research; 93.395, Cancer communicate with the CSAP Council’s following methods:

VerDate Sep<11>2014 00:05 Jan 11, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\11JAN1.SGM 11JAN1
Document Created: 2018-01-11 04:54:25
Document Modified: 2018-01-11 04:54:25
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		February 6, 2018.
FR Citation		83 FR 1377
83 FR 1377 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 8 (January 11, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
